Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series
Thao Truong, Alex Ryutov, Utsav Pandey, et al.
EBioMedicine (2021) Vol. 67, pp. 103355-103355
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

SARS-CoV-2 Variants in Patients with Immunosuppression
Lawrence Corey, Chris Beyrer, Myron S. Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 6, pp. 562-566
Open Access | Times Cited: 410
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 311
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
Changshuo Wei, Ke-Jia Shan, Wei‐Guang Wang, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 12, pp. 1111-1121
Open Access | Times Cited: 268
Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Kuldeep Dhama, Firzan Nainu, Andri Frediansyah, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 4-14
Open Access | Times Cited: 199
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, et al.
Journal of General Virology (2021) Vol. 102, Iss. 4
Open Access | Times Cited: 166
Viral variant-resolved wastewater surveillance of SARS-CoV-2 at national scale
Fabian Amman, Rudolf Markt, Lukas Endler, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 12, pp. 1814-1822
Open Access | Times Cited: 147
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish, Carleen Klumpp‐Thomas, Sally Hunsberger, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 601
Open Access | Times Cited: 132
Drivers of adaptive evolution during chronic SARS-CoV-2 infections
Sheri Harari, Maayan Tahor, Natalie Rutsinsky, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1501-1508
Open Access | Times Cited: 129
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
Jonathon W. Senefeld, Massimo Franchini, Carlo Mengoli, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2250647-e2250647
Open Access | Times Cited: 127
COVID‐19 vaccinations: The unknowns, challenges, and hopes
Kawthar Mohamed, Piotr Rzymski, Md Shahidul Islam, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1336-1349
Open Access | Times Cited: 119
Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks
Katarina M. Braun, Gage K. Moreno, Cassia Wagner, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 8, pp. e1009849-e1009849
Open Access | Times Cited: 104
Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection
Farina Karim, MYS Moosa, BI Gosnell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 102
SARS-CoV-2 in immunocompromised individuals
Susan DeWolf, Justin C. Laracy, Miguel‐Angel Perales, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1779-1798
Open Access | Times Cited: 88
COVID-19: Challenges of Viral Variants
Jana L. Jacobs, Ghady Haidar, John W. Mellors
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 31-53
Open Access | Times Cited: 84
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Manuela Di Fusco, Jay Lin, Shailja Vaghela, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 4, pp. 435-451
Open Access | Times Cited: 78
Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection
Chrispin Chaguza, Anne M. Hahn, Mary E. Petrone, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100943-100943
Open Access | Times Cited: 73
Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants
Ana S. González-Reiche, Hala Alshammary, Sarah Schaefer, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 59
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Mireille Farjo, Katia Koelle, Michael A. Martin, et al.
Journal of Virology (2024) Vol. 98, Iss. 1
Open Access | Times Cited: 17
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 15
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study
Galia Rahav, Yaniv Lustig, Jacob Lavee, et al.
EClinicalMedicine (2021) Vol. 41, pp. 101158-101158
Open Access | Times Cited: 78
Use of convalescent plasma inCOVID‐19 patients with immunosuppression
Jonathon W. Senefeld, Stephen A. Klassen, Shane Ford, et al.
Transfusion (2021) Vol. 61, Iss. 8, pp. 2503-2511
Open Access | Times Cited: 76
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection
Manish C. Choudhary, Charles R. Crain, Xueting Qiu, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 2, pp. 237-245
Open Access | Times Cited: 74
SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives
Samuel Long
Viruses (2021) Vol. 13, Iss. 10, pp. 1923-1923
Open Access | Times Cited: 57
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
Judith M. White, Joshua T. Schiffer, Rachel Bender Ignacio, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top